Peptide could help block flu pandemic

A peptide which prevents flu viruses replicating has been discovered by US researchers.

They hope to use the molecule to develop a novel type of antiviral drug that would protect against all strains of influenza, including the H5N1 bird flu virus. 

The 20-amino acid peptide, derived from the signal sequence of fibroblast growth factor-4, works by blocking the influenza virus’ ability to attach to a key cell surface molecule. This stops the virus from entering the cell and prevents it replicating.  

Researchers tested the effects  on cultured canine kidney cells exposed to six different strains of H5N1 and H1N1 influenza. Treated cells did not die.  

They then tested the peptide on mice exposed to a lethal strain of H5N1. All the mice treated with the peptide survived.  

The researchers concluded that a drug based on this molecule could be more effective than existing antivirals for preventing a flu pandemic.  

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Fitness to practise and revalidation to continue despite pandemic, GMC confirms

Revalidation and ongoing fitness to practise cases will continue despite huge pressure...

UK COVID-19 vaccination programme tracker

UK COVID-19 vaccination programme tracker

GPs across the UK are playing a leading role in the largest-ever NHS vaccination...

Supporting men and children experiencing domestic violence through general practice

Supporting men and children experiencing domestic violence through general practice

IRIS is an evidence-based programme designed to reach female survivors of domestic...

Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar

Learn about neurological aspects of 'long COVID' at a MIMS Learning webinar

Loss of taste and smell and neurological aspects of 'long COVID' infection will be...

COVID-19 vaccine stocks must not be diverted to large sites ahead of local GPs, warns BMA

COVID-19 vaccine stocks must not be diverted to large sites ahead of local GPs, warns BMA

The government must ‘ramp up’ COVID vaccine supplies to general practice and avoid...

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led sites behind almost three quarters of COVID-19 jabs in England

GP-led vaccination sites have delivered nearly three quarters of COVID-19 vaccine...